{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:17:37Z","timestamp":1780118257235,"version":"3.54.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1002\/jps.21362","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T21:16:27Z","timestamp":1205961387000},"page":"4857-4868","source":"Crossref","is-referenced-by-count":48,"title":["Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy"],"prefix":"10.1016","volume":"97","author":[{"given":"Jagdeep","family":"Shur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Nevell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Barbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy H.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis K.","family":"Shute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21362_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/09031936.03.00057003","article-title":"New concepts of the pathogenesis of cystic fibrosis lung disease","volume":"23","author":"Boucher","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.21362_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1002\/jps.21362_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","article-title":"Evidence for airway surface dehydration as the initiating event in CF airway disease","volume":"261","author":"Boucher","year":"2007","journal-title":"J Int Med"},{"key":"10.1002\/jps.21362_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prrv.2007.02.004","article-title":"Mucus structure and properties in cystic fibrosis","volume":"8","author":"Rubin","year":"2007","journal-title":"Pediatr Respir Rev"},{"key":"10.1002\/jps.21362_bb0030","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/j.prrv.2006.04.198","article-title":"The pharmacologic approach to airway clearance: Mucoactive agents","volume":"7S","author":"Rubin","year":"2006","journal-title":"Pediatr Respir Rev"},{"key":"10.1002\/jps.21362_bb0035","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.carres.2006.04.014","article-title":"Semi-synthetic heparin derivatives: Chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo\/N-acetyl groups","volume":"341","author":"Fern\u00e1ndez","year":"2006","journal-title":"Carbohydr Res"},{"key":"10.1002\/jps.21362_bb0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2222.1998.00283.x","article-title":"Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin","volume":"28","author":"Ramdin","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1002\/jps.21362_bb0045","doi-asserted-by":"crossref","first-page":"L1240","DOI":"10.1152\/ajplung.00206.2007","article-title":"Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis","volume":"293","author":"Broughton-Head","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1002\/jps.21362_bb0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.06.00069005","article-title":"Inhaled heparin in cystic fibrosis","volume":"27","author":"Serisier","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.21362_bb0055","doi-asserted-by":"crossref","unstructured":"Shur J, Nevell TG, Shute JK, Smith JR. in press. The spray drying of unfractionated heparin: Optimisation of the operating parameters. Drug Dev Ind Pharm.","DOI":"10.1080\/03639040701657552"},{"key":"10.1002\/jps.21362_bb0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2005.09.004","article-title":"The influence of formulation components on the aerosolisation properties of spray-dried powders","volume":"110","author":"Rabbani","year":"2005","journal-title":"J Control Release"},{"key":"10.1002\/jps.21362_bb0065","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/jps.20426","article-title":"Effect of amino acids on the dispersion of disodium cromoglycate powders","volume":"94","author":"Chew","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21362_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.07.027","article-title":"The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine","volume":"285","author":"Najafabadi","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21362_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jam.1994.7.49","article-title":"Drug-delivery via the respiratory-tract","volume":"7","author":"Byron","year":"1994","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.21362_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ppul.10134","article-title":"Detecting early structural lung damage in cystic fibrosis","volume":"34","author":"Tiddens","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/jps.21362_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/sia.740030506","article-title":"Empirical atomic sensitivity factors for quantitative-analysis by electron-spectroscopy for chemical-analysis","volume":"3","author":"Wagner","year":"1981","journal-title":"Surf Interf Anal"},{"key":"10.1002\/jps.21362_bb0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0006-291X(76)90558-1","article-title":"Separation of active and inactive forms of heparin","volume":"69","author":"Lam","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.21362_bb0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/BIR-1987-24611","article-title":"The role of mucus viscoelasticity in cough clearance","volume":"24","author":"King","year":"1987","journal-title":"Biorheol"},{"key":"10.1002\/jps.21362_bb0100","series-title":"Introduction to rheology","author":"Barnes","year":"2001"},{"key":"10.1002\/jps.21362_bb0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF02510101","article-title":"Heparin determination by spectrophotometric and photocolorimetric methods","volume":"33","author":"Khokhlov","year":"1999","journal-title":"Pharm Chem J"},{"key":"10.1002\/jps.21362_bb0110","article-title":"Heparin: From animal organ extract to designer drug","author":"Middeldorp","year":"2007","journal-title":"Thrombosis Res."},{"key":"10.1002\/jps.21362_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM200103013440910","article-title":"Redesigning heparin","volume":"344","author":"Rosenburg","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.21362_bb0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbm.a.10020","article-title":"Surface functionalization and grafting of heparin and\/or rgd by an aqueous-based process to a poly(carbonate-urea)urethane cardiovascular graft for cellular engineering applications","volume":"66A","author":"Salacinski","year":"2003","journal-title":"J Biomed Mater Res A"},{"key":"10.1002\/jps.21362_bb0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.eurpolymj.2003.12.002","article-title":"Synthesis, characterization and gold loading of polystyrene-poly(pyridyl methacrylate) core-shell latex systems","volume":"40","author":"Ol\u00e1h","year":"2004","journal-title":"Eur Polym J"},{"key":"10.1002\/jps.21362_bb0130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.5194\/acp-5-1951-2005","article-title":"Impact of palmitic acid coating on the water uptake and loss of ammonium sulphate particles","volume":"5","author":"Garland","year":"2005","journal-title":"Atmos Chem Phys"},{"key":"10.1002\/jps.21362_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/0894268041457219","article-title":"The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the deliverv of pumactant for inhalation therapy","volume":"17","author":"Young","year":"2004","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.21362_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejps.2005.11.013","article-title":"Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer (R)) for high powder doses","volume":"28","author":"de Boer","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21362_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1183\/09031936.93.03010019","article-title":"The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum","volume":"3","author":"Lethem","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.21362_bb0150","series-title":"Statistics using ranks. A unified approach","author":"Meddis","year":"1984"},{"key":"10.1002\/jps.21362_bb0155","series-title":"Cilia Mucus Mucociliary Interact","first-page":"333","article-title":"DNA and actin filament ultrastructure in cystic fibrosis sputum.","author":"Tomkiewicz","year":"1998"},{"key":"10.1002\/jps.21362_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bpc.2004.07.019","article-title":"Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients","volume":"112","author":"Nielsen","year":"2004","journal-title":"Biophys Chem"},{"key":"10.1002\/jps.21362_bb0165","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.21362_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/thx.51.2.119","article-title":"In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis","volume":"51","author":"Shah","year":"1996","journal-title":"Thorax"},{"key":"10.1002\/jps.21362_bb0175","first-page":"A671","article-title":"Sputum pharmacodynamics and pharmacokinetics of recombinant human DNase I in cystic fibrosis","volume":"149","author":"Sinicropi","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.21362_bb0180","first-page":"319","article-title":"Molecular basis for mucolytic therapy","volume":"2","author":"Dasgupta","year":"1995","journal-title":"Cancer Respir J"},{"key":"10.1002\/jps.21362_bb0185","first-page":"868","article-title":"Evaluating the efficacy of mucoactive aerosol therapy","volume":"45","author":"Fuloria","year":"2000","journal-title":"Respir Care"},{"key":"10.1002\/jps.21362_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1099-0496(199704)23:4<243::AID-PPUL1>3.0.CO;2-N","article-title":"Retrospective review of the effects of rhDNase in children with cystic fibrosis","volume":"23","author":"Davies","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/jps.21362_bb0195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004310050046","article-title":"DNase use in the daily care of cystic fibrosis: Who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres","volume":"159","author":"Cobos","year":"2000","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916373233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916373233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T04:47:40Z","timestamp":1684298860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916373233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0022354916373233"],"URL":"https:\/\/doi.org\/10.1002\/jps.21362","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}